PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30078020-9	2018	Capsid tyrosine-modified rAAV5-CD40L-M was packaged and carried out in vivo.	Tyrosine	7-15	CD40 ligand	Homo sapiens	31-38	
9916733-7	1999	In B cells isolated from PBMC of AD patients with high serum IgE levels, JAK3 was constitutively phosphorylated at the tyrosine residue, and its phosphorylation was enhanced by the treatment with CD40L and/or IL-4 as was that in splenic B cells of NC/Nga mice with dermatitis and high IgE levels.	Tyrosine	119-127	CD40 ligand	Homo sapiens	196-201	
9345261-3	1997	Activation of T-lymphocytes via CD40L induces tyrosine phosphorylation of cellular proteins including PLC gamma.	Tyrosine	46-54	CD40 ligand	Homo sapiens	32-37	
9345261-5	1997	Inhibition of src-like tyrosine kinases by Herbimycin A prevents these activation events suggesting a crucial role of tyrosine phosphorylation in T-lymphocyte activation via CD40L.	Tyrosine	23-31	CD40 ligand	Homo sapiens	174-179	
7513724-10	1994	Neutralizing Abs directed against gp39 inhibited PMAct-induced protein tyrosine phosphorylation of B cell substrates.	Tyrosine	71-79	CD40 ligand	Homo sapiens	34-38	
31479717-10	2019	WW + Tyr improved endothelial function, increased plasma HDL-cholesterol and antithrombin IIII, and decreased plasma homocysteine, endothelin 1, and CD40L, P65/RELA, and CFH gene expression in peripheral blood mononuclear cells (p < 0.05).	Tyrosine	5-8	CD40 ligand	Homo sapiens	149-154	
16186418-2	2005	Here, we show how CD40L increases vascular inflammation and thrombosis via tyrosine nitration and inhibition of prostacyclin synthase (PGIS), an enzyme with antithrombotic, antiproliferative, and dilatory functions in the normal vasculature.	Tyrosine	75-83	CD40 ligand	Homo sapiens	18-23	
15067037-5	2004	The tyrosine phosphorylation of CD28i followed the cross-linking of CD40L, and the overexpression of CD28i augmented the c-Jun NH2-terminal kinase, p21-activated kinase 2, and nuclear factor kappaB activation.	Tyrosine	4-12	CD40 ligand	Homo sapiens	68-73	
16037832-5	2005	The diagnosis of XHIGM was confirmed by the finding of CD40L expression < 1% of normal and a tyrosine 169 asparaginase (t526a) mutation in exon 5 (the tumor necrosis factor domain) of the CD40L gene.	Tyrosine	93-101	CD40 ligand	Homo sapiens	188-193